Applied DNA Sciences, Inc.

PRESS RELEASE

published on 02/08/2024 at 22:05, 2 years 5 months ago

Applied DNA Announces First Quarter Fiscal Year 2024 Financial Results
Applied DNA Sciences, Inc. (NASDAQ:APDN) announces Q1 fiscal year 2024 financial results and progress on GMP production capacity for mRNA therapeutics. Projects initial facility capacity to enable up to $15 million Linea IVT revenue annually

Financial Results Applied DNA Sciences MRNA Therapeutics GMP Production Capacity Linea IVT Revenue
PRESS RELEASE

published on 02/05/2024 at 19:00, 2 years 5 months ago

Applied DNA to Report First Quarter Fiscal 2024 Financial Results on Thursday, February 8, 2024
Applied DNA Sciences, Inc. will release first quarter fiscal 2024 financial results after market close on February 8, 2024, with a conference call for analysts. The company operates in biotechnology developing DNA detection and production technologies

Financial Results Conference Call Biotechnology Applied DNA Sciences DNA Detection
PRESS RELEASE

published on 02/02/2024 at 22:15, 2 years 5 months ago

Applied DNA Announces Closing of $3.44 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Applied DNA Sciences, Inc. closes registered direct offering of common stock priced at-the-market with institutional investors. Proceeds to be used for therapeutic DNA production services

Registered Direct Offering Institutional Investors Common Stock Applied DNA Sciences DNA Technologies
PRESS RELEASE

published on 01/31/2024 at 14:00, 2 years 5 months ago

Applied DNA Announces $3.44 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Applied DNA Sciences, Inc. announces a registered direct offering and a concurrent private placement to certain existing institutional investors. Maxim Group LLC acts as exclusive placement agent

Registered Direct Offering Applied DNA Sciences Securities Purchase Agreements Maxim Group LLC DNA Technologies
PRESS RELEASE

published on 12/14/2023 at 14:00, 2 years 7 months ago

Applied DNA Announces Joint Development Agreement to Integrate Linea(TM) IVT Platform into CDMO Kudo Biotechnology’s mRNA Manufacturing Workflow
PRESS RELEASE

published on 12/07/2023 at 22:05, 2 years 7 months ago

Applied DNA Announces Fourth Quarter Fiscal Year 2023 Financial Results
PRESS RELEASE

published on 12/05/2023 at 14:30, 2 years 7 months ago

Applied DNA to Report Fiscal 2023 Fourth Quarter and Year End Financial Results on December 7, 2023
Applied DNA Sciences, Inc. (NASDAQ:APDN) will release its Q4 and full year 2023 financial results on December 7, 2023, after the market close. A conference call for investors will follow to discuss the results

Financial Results Conference Call Investor Relations Applied DNA Sciences NASDAQ:APDN
PRESS RELEASE

published on 11/28/2023 at 14:30, 2 years 7 months ago

Applied DNA Announces Receipt of Linea(TM) DNA Follow-On Order for Cancer Diagnostic Application
PRESS RELEASE

published on 11/16/2023 at 14:30, 2 years 8 months ago

Applied DNA Extends Application of Linea(TM) IVT Platform to saRNA (self-amplifying mRNA)
PRESS RELEASE

published on 11/09/2023 at 15:15, 2 years 8 months ago

Applied DNA Ships First saRNA (self-amplifying mRNA) IVT Template Generated by Linea(TM) DNA Platform

Published on 07/21/2026 at 23:00, 41 minutes ago

Viemed Healthcare Announces Second Quarter 2026 Earnings Conference Call Details
Published on 07/21/2026 at 22:30, 1 hour 11 minutes ago

Fermi Announces First Siemens Turbines Arrive at Port of Houston
Published on 07/21/2026 at 22:30, 1 hour 11 minutes ago

Matador Technologies Announces Management Transition
Published on 07/21/2026 at 22:15, 1 hour 26 minutes ago

Vanta Announces Updated Time for Participation in the "Health, Wellness & Longevity" Virtual Conference Presented by Maxim Group LLC on Wednesday, July 22, 2026, at 12:00 p.m. ET
Published on 07/21/2026 at 22:00, 1 hour 41 minutes ago

Redwood AI Announces Closing of $3.5 Million Private Placement

View all ACCESSWIRE

Published on 07/21/2026 at 22:30, 1 hour 10 minutes ago

Strong second quarter: GEA raises full-year guidance for 2026
Published on 07/21/2026 at 22:16, 1 hour 24 minutes ago

EQS-Adhoc: GEA Group Aktiengesellschaft: Preliminary numbers for Q2 2026 exceed market expectation - increase of guidance for fiscal year 2026
Published on 07/21/2026 at 18:50, 4 hours 50 minutes ago

Soapeya, a DN Group AG Portfolio Company, Earns Top "Excellent" Rating from Dermatest and Proves Successful in Field Use in Ghana
Published on 07/21/2026 at 18:15, 5 hours 25 minutes ago

EuroTeleSites Reports Strong Q2/2026 Results with Growth Across Key Financial and Operating Metrics
Published on 07/21/2026 at 17:50, 5 hours 50 minutes ago

The New Measure of an EV Isn't Range, It's Peace of Mind

View all EQS

Published on 07/21/2026 at 18:41, 4 hours 59 minutes ago

ICADE - 2026 HY Financial Report
Published on 07/21/2026 at 18:13, 5 hours 27 minutes ago

ICADE – PR – 2026 HALF YEAR RESULTS
Published on 07/20/2026 at 18:20, 1 day 5 hours ago

Covivio - 2026 Half-year results: Earnings growth driven by active asset management
Published on 07/20/2026 at 18:04, 1 day 5 hours ago

Reporting on share buyback transactions carried out between July 8 and July 9, 2026
Published on 07/20/2026 at 17:45, 1 day 5 hours ago

Weekly share buyback

View all LES ECHOS COMFI WIRE

News